Michael A. Pleiss
86Patents
15h-index
94Co-inventors
87Inventor score
Filing activity: Jun 6, 1995 → Aug 17, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7049306B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. | Emerging Cross-Sectional Technologies | 70 | Expired |
| US6407066B1 | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 30 | Expired |
| US6583139B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 29 | Expired |
| US7026328B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 29 | Expired |
| US7008949B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Human Necessities | 28 | Expired |
| US6492421B1 | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 26 | Expired |
| US6492372B1 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6479492B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6436904B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 18 | Expired |
| US6903088B2 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7135477B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 15 | Expired |
| US7101855B2 | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 15 | Expired |
| US6689781B2 | Phenylalanine derivatives as alpha 4 integrin inhibitors | Human Necessities | 15 | Expired |
| US6653303B1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds | Chemistry; Metallurgy | 15 | Expired |
| US6544978B2 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds | Chemistry; Metallurgy | 15 | Expired |
| US7005433B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6911439B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6545003B1 | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 14 | Expired |
| US6974829B2 | Succinoyl aminopyrazoles and related compounds | Chemistry; Metallurgy | 13 | Expired |
| US7378529B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7427628B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 13 | Active |
| US6489300B1 | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 13 | Expired |
| US6001809A | Inhibitors of leukocyte adhesion | Human Necessities | 12 | Expired |
| US7335663B2 | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins | Human Necessities | 10 | Expired |
| US7452912B2 | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 10 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.